Selected article for: "clinical trial and global pandemic"

Author: Jovic, Thomas H; Ali, Stephen R; Ibrahim, Nader; Jessop, Zita M; Tarassoli, Sam P; Dobbs, Thomas D; Holford, Patrick; Thornton, Catherine A; Whitaker, Iain S
Title: Could Vitamins Help in the Fight Against COVID-19?
  • Cord-id: fl7kzqyv
  • Document date: 2020_8_23
  • ID: fl7kzqyv
    Snippet: There are limited proven therapeutic options for the prevention and treatment of COVID-19. The role of vitamin and mineral supplementation or “immunonutrition” has previously been explored in a number of clinical trials in intensive care settings, and there are several hypotheses to support their routine use. The aim of this narrative review was to investigate whether vitamin supplementation is beneficial in COVID-19. A systematic search strategy with a narrative literature summary was desig
    Document: There are limited proven therapeutic options for the prevention and treatment of COVID-19. The role of vitamin and mineral supplementation or “immunonutrition” has previously been explored in a number of clinical trials in intensive care settings, and there are several hypotheses to support their routine use. The aim of this narrative review was to investigate whether vitamin supplementation is beneficial in COVID-19. A systematic search strategy with a narrative literature summary was designed, using the Medline, EMBASE, Cochrane Trials Register, WHO International Clinical Trial Registry, and Nexis media databases. The immune-mediating, antioxidant and antimicrobial roles of vitamins A to E were explored and their potential role in the fight against COVID-19 was evaluated. The major topics extracted for narrative synthesis were physiological and immunological roles of each vitamin, their role in respiratory infections, acute respiratory distress syndrome (ARDS), and COVID-19. Vitamins A to E highlighted potentially beneficial roles in the fight against COVID-19 via antioxidant effects, immunomodulation, enhancing natural barriers, and local paracrine signaling. Level 1 and 2 evidence supports the use of thiamine, vitamin C, and vitamin D in COVID-like respiratory diseases, ARDS, and sepsis. Although there are currently no published clinical trials due to the novelty of SARS-CoV-2 infection, there is pathophysiologic rationale for exploring the use of vitamins in this global pandemic, supported by early anecdotal reports from international groups. The final outcomes of ongoing trials of vitamin supplementation are awaited with interest.

    Search related documents:
    Co phrase search for related documents
    • adaptive immune response and low vitamin: 1
    • adaptive immune response and lps lipopolysaccharide: 1
    • adaptive immune response and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adaptive immune system and adhesion molecule: 1
    • adaptive immune system and low quality: 1
    • adaptive immune system and low vitamin: 1, 2, 3
    • adaptive immune system and lps lipopolysaccharide: 1, 2, 3
    • adaptive immune system and lung injury: 1, 2, 3
    • adaptive immune system and lung parenchyma: 1
    • adaptive immune system and lymphatic system: 1
    • adaptive immune system and macrophage neutrophil: 1, 2, 3
    • adaptive immunity and low concentration: 1
    • adaptive immunity and low vitamin: 1
    • adaptive immunity and lps lipopolysaccharide: 1
    • adaptive immunity and lung injury: 1, 2, 3, 4, 5, 6, 7
    • adaptive immunity and lung parenchyma: 1
    • adaptive immunity and lymphatic system: 1
    • adaptive immunity and macrophage neutrophil: 1
    • adhesion molecule and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15